Product NDC: | 76282-237 |
Proprietary Name: | Amlodipine besylate |
Non Proprietary Name: | Amlodipine besylate |
Active Ingredient(s): | 2.5 mg/1 & nbsp; Amlodipine besylate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 76282-237 |
Labeler Name: | Exelan Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077955 |
Marketing Category: | ANDA |
Start Marketing Date: | 20071102 |
Package NDC: | 76282-237-10 |
Package Description: | 1000 TABLET in 1 BOTTLE (76282-237-10) |
NDC Code | 76282-237-10 |
Proprietary Name | Amlodipine besylate |
Package Description | 1000 TABLET in 1 BOTTLE (76282-237-10) |
Product NDC | 76282-237 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Amlodipine besylate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20071102 |
Marketing Category Name | ANDA |
Labeler Name | Exelan Pharmaceuticals, Inc. |
Substance Name | AMLODIPINE BESYLATE |
Strength Number | 2.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |